Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Alastair McIntosh who wrote (40315)	9/28/2015 12:19:48 AM
From: i-node	Respond to of 42652

>> I would be more interested in whether or not paying $500,000 USD That's going to be a hard call, sooner or later. Whether it is 500K or 1M or 5M, eventually it will have to be dealt with. But I think it is always important to consider the ancillary benefit that eventually, the drug will be off-patent and can be manufactured cheaply, and in addition, these guys are at least putting significant profits back into the pipeline. The example from a week or two ago, there was no indication at all other than the guy's word that that was going to happen. It does seem to me when you tell the ratepayers that you're going to remove the limitations on benefits for commercial insurance you do open the door. As a practical matter, if I have to have that drug I'm going to find a commercial payer who will pay it and I'm changing my policy to them, because that is the social contract. I can't be denied coverage. I imagine there are a lot of these battles yet to be played out.